What question did this study set out to answer?

To evaluate the impact of combined treatment with finerenone and empagliflozin on urinary albumin-to-creatinine ratio.

March 28, 2026Open Access

Wcn26-8665 Confidence Asia: Effect of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in Asian Participants From the Confidence Trial

Key Points

To evaluate the impact of combined treatment with finerenone and empagliflozin on urinary albumin-to-creatinine ratio.
Conducted within the CONFIDENCE trial framework.
Focused on Asian participants with diabetic kidney disease.
Utilized a urinary albumin-to-creatinine ratio measure for analysis.
Observed reductions in urinary albumin-to-creatinine ratio.
Implies improved albuminuria management in participants on combined therapy.

Abstract

Conclusion: Moringa oleifera leaf extract lower albuminuria levels in male Sprague dawley mice in a DKD model I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.

AI से पूछें

Bookmark

View Full Paper